Abstract The Cre/loxP system has been widely used to generate tissue-specific gene knockout mice. Inducible (Tetoff) Osx-GFP::Cre (Osx-Cre) mouse line that targets osteoblasts is widely used in the bone research field. In this study, we investigated the effect of Osx-Cre on craniofacial bone development. We found that newborn Osx-Cre mice showed severe hypomineralization in parietal, frontal, and nasal bones as well as the coronal sutural area when compared to control mice. As the mice matured, the intramembranous bone hypomineralization phenotype became less severe. The major hypomineralization defect in parietal, frontal, and nasal bones had mostly disappeared by postnatal day 21, but the defect in sutural areas persisted. Importantly, Doxycycline treatment eliminated cranial bone defects at birth which indicates that Cre expression may be responsible for the phenotype. In addition, we showed that the primary calvarial osteoblasts isolated from neonatal Osx-Cre mice had comparable differentiation ability compared to their littermate controls. This study reinforces the idea that Crepositive litter mates are indispensable controls in studies using conditional gene deletion.
Introduction
The Cre/loxP system has been widely used to generate tissue-specific gene knockout mice. Two strains of mice, one with a Cre insertion and the other with a loxP insertion, are bred to generate offspring with the tissue-specific gene knockout. The application of this technology has greatly advanced our understanding of the functions of numerous genes in a wide range of disciplines including bone research. Bone is a heterogeneous tissue dynamically regulated by osteoblasts and osteoclasts as well as other cell types. The availability of Cre mouse lines targeting various bone cells has increased our ability to dissect cell typespecific roles by targeting genes in both a cell-and development stage-specific manner.
In the past decade, several Cre mouse lines have been generated which target osteoblasts [1] [2] [3] [4] [5] . Osx-GFP::Cre (Osx-Cre) mice are commonly used to target osteoblasts; they have a tTA and a tetracycline-responsive element-controlled GFP/Cre fusion protein under the control of the Osterix (Sp7) promoter [2] . It has been shown that Osx-Cre is expressed during embryonic development from E14.5 and postnatally in both osteoblasts and sporadically in hypertrophic chondrocytes [2] . Breeding Osx-Cre mice with a floxed mouse line, where the target gene loci is flanked by loxP sites, generates a Cre/loxP knockout mouse with targeted gene deletion occurring in osteoblasts. Treatment with doxycycline can prevent the expression of the GFP-Cre fusion protein and recombination of the target gene. Therefore, this system allows cell type-and time-specific gene targeting [2, 6] .
It is ideal to include both floxed and Cre transgenic littermate controls in Cre/loxP breeding experiments to ensure accurate interpretation of any observed phenotype. Mating schemes capable of generating genotypes including flox, Cre control, and conditional knockout (CKO) mice are inefficient at producing Cre control and CKO in one litter. For this practical reason, many researchers did not include a Cre control group and used only a flox control group instead. This is indeed true for most of the gene targeting research with the Osx-Cre mouse line. When we used the Osx-Cre transgenic mouse line to generate conditional knockout mice for our gene of interest, we found severely defective intramembranous bone development when compared to the flox control mice. Interestingly, a similar defective intramembranous bone development phenotype has been reported in several other CKO mouse models using Osx-Cre [7] [8] [9] . It has been documented that there is decreased body weight in young Osx-Cre transgenic mice resulting in delayed cortical bone expansion and accrual [10] . It is known that the Cre transgene itself may have non-specific effects [11] . This prompted us to question whether defective bone development in our CKO mouse models was due to the Osx-Cre itself. Therefore, we investigated the effect of Osx-Cre on early postnatal bone development. We showed that the Osx-Cre transgene itself had no effect on the trabecular bone parameters and minimal effect on the cortical parameters for one-month-old C57BL/6 background mice [12] . However, we noted that there is defective intramembranous bone development in Osx-Cre mice. This finding is of particular importance considering the increasing use of the Osx-Cre mouse line to generate osteoblast-specific knockouts. This study underscores the importance of including Cre-positive littermate controls for comparison with CKOs.
Materials and Methods

Animals and Genotyping
The Osx-Cre transgenic mouse line was described previously [2] . Osx-Cre mice were bred with Rosa 26 reporter mice [13] to generate Rosa26;Osx-Cre mice that bring reporter gene LacZ. Osx-Cre mice have been backcrossed to C57BL/6 background for at least 9 generations. Rosa 26 reporter mice have been backcrossed to C57BL/6 background for at least 5 generations. All mice used in this study were maintained and handled according to local, state, and federal regulation, and were approved by the Institutional Animal Care and Use Committee at the University of Michigan. Mice were fed with 5001 or 5008 rodent diet (LabDiet). To suppress Cre activity, designated breeders were fed a diet containing 625 mg/kg doxycycline (Harlan, USA) to deliver a daily dose of 2-3 mg/mouse of doxycycline according to manufacturer's instruction. Mice were genotyped by PCR using tail DNA and primers (Cre and Rosa26) as previously described [14] . Primer sequences are available upon request.
Skeleton Preparation and Staining
Skeleton preparation and staining of mice at different ages was described in previous studies [15] . Briefly, after fixation with 95 % ethanol for 48 h, skeletons were stained with 0.015 % Alcian blue in 80 % ethanol and 20 % acetic acid solution for overnight, and then digested by 2 % KOH for 24 h, followed by 0.015 % Alizarin red in (1 % KOH solution) staining for 24 h. Samples were finally maintained in 1:1 mixture of glycerol and 95 % ethanol for analysis.
Primary Calvaria Culture and Histochemical Assay Isolation and culture of calvarial cells from neonatal mice were described previously [12] . Cells were plated and cultured in 6-cm dish in alpha MEM containing 10 % heatinactivated FBS till analysis. Alkaline phosphatase staining (ALP) was performed for osteoblast differentiation using a commercial kit (Sigma Diagnostics, USA), all procedures were according to the manufacturer's instructions. Modified Alizarin red staining (AR) was performed for mineralization analysis. In brief, cells were fixed for 1 h with cold 70 % ethanol and stained with 40 mM AR-S, pH 4.2, at room temperature for 10 min with rotation.
Histology and Fluorescence Microscopy
Histology was performed as described previously [12] . Primary calvarial osteoblasts isolated from Osx-Cre transgenic mice were observed with fluorescence microscope directly.
RNA Extraction and qRT-PCR
RNA extraction and qRT-PCR were performed as previously described [12] . Total RNA of mouse frontal and nasal bones was extracted using the Trizol reagent (Invitrogen, USA), and 1 ug of total RNA (equal amount) per sample was reverse transcribed using first strand RT kit (Invitrogen, USA). Quantitative real time PCR (qRT-PCR) was performed using SYBR Green Supermix (Qiagen, USA) with primers that sequence information are available upon request. The level of target gene expression was normalized to the level of the reference gene 18S rRNA as described previously [12] .
X-gal Staining X-gal (5-bromo-4-chloro-3-indolyl-b-d-galactopyranoside) staining was performed for b-galactosidase activity assay. In brief, calvariae were dissected and rinsed with PBS, fixed in 4 % PFA for 20 min at room temperature, rinsed with PBS again, and then stained 5 h in X-gal solution containing 1 mg/mL X-gal (Invitrogen, USA), 5 mM potassium ferricyanide, 2 mM MgCl2, 0.01 % sodium deoxycholate, and 0.02 % NP-40 at 37°C.
Statistical Analysis
Statistical differences were evaluated by Mann-Whitney test (Student's t test). A value of P \ 0.05 was considered to be statistical significance.
Results
Intramembranous Bone Formation is Defective in Osx-Cre Mice
We previously characterized the effect of Osx-Cre transgene on the endochondrally formed femur and vertebra in one-month-old mice and found no adverse effect on the trabecular compartment of either bone [12] . In this study, we focused on the effect of the Osx-Cre transgene on intramembranous bone formation in the first 3 weeks postnatally. At birth, there is no body weight difference between control mice and Osx-Cre mice ( Fig. 1) . However, the body weight of Osx-Cre mice is significantly decreased after 1 week. As a first step to investigate the early bone development in these mice, we performed whole skeleton staining in newborn pups. Surprisingly, severe hypomineralization of nasal, frontal, and parietal bone was observed in Osx-Cre-positive skulls compared to controls (Fig. 2a,  b) . This indicates defective intramembranous bone formation. The coronal sutural area had severe hypomineralization in Osx-Cre mice (Fig. 2a) . We performed skeleton staining on more than 20 Osx-Cre newborn pups and all pups showed a similar phenotype which indicates high penetrance. Histological examination in the nasal bone area showed significantly diminished mineralized tissue in the nasal bone of Osx-Cre mice (Fig. 2b) . Except for the craniofacial bone defects, Osx-Cre mice had no obvious developmental defects in other major skeletal elements we examined including the humerus, radius and ulna, femur, tibia, fibula, ribs, and vertebrae (Fig. 2c) suggesting that endochondral bone formation was not affected at birth.
Hypomineralization of Intramembranous Bone in OsxCre Mice Gradually Recovers During Development
To further determine the extent of hypomineralization in Osx-Cre mice, we assessed skull development by performing skeleton staining at different postnatal time points. At day 7, hypomineralization in frontal, parietal, and nasal bones of Osx-Cre mice persisted; however, it was much less severe compared to the defects present at birth (Fig. 3a) . The mineralization defect in coronal sutural area was the most prominent. At this stage, the staining pattern in other parts of the body was normal except that Osx-Cre mice had slightly shorter tibia and humerus (data not shown). At day 14, hypomineralization in frontal, parietal, and nasal bones was further diminished (Fig. 3b) . Minor, but still noticeable, defects existed in frontal and parietal bones. Hypomineralization persisted in coronal sutural area and started to become evident in the metopic sutural area. At day 21, the parietal bone in Osx-Cre mice appears normal. Very few minor porous spots were noticed in the frontal and nasal bones. The hypomineralization in coronal and metopic sutural areas continued to be evident (Fig. 3c) . To determine the contribution Cre expression has in the observed hypomineralization phenotype, we measured Cre expression in the calvaria of Osx-Cre mice and found that there was higher Cre expression at birth relative to day 21 (Fig. 4a) . The association between Cre expression level and hypomineralization phenotype severity suggests higher Cre expression at birth may contribute to the phenotype. In addition, we measured the Osterix mRNA expression and found that Osterix mRNA levels did not differ between control and Osx-Cre mice (Fig. 4b) . We found decreased Osterix mRNA expression at day 21 compared to that at birth which is consistent with Cre expression. We measured osteoblast differentiation marker expression to determine to what extent defective osteoblast differentiation may contribute to the hypomineralization. As expected, the expression of Alkaline phosphatase, liver/bone/ kidney (Alpl), Runt-related transcription factor 2 (Runx2), and Bone gamma carboxyglutamate protein (also known as osteocalcin, Ocn) was increased at later development stage (day 21) compared to at birth in both control and Osx-Cre groups (Fig. 4c-e) . In contrast, Bone sialoprotein (Bsp) expression was decreased at later development stage (Fig. 4f) , indicating that calvaria at early development stage has more robust Bsp expression. However, we found no differential expression in any of those genes between control and Osx-Cre mice at either time point.
Doxycycline Treatment Rescues Hypomineralization Phenotype in Osx-Cre Mice
To determine whether the hypomineralization phenotype in Osx-Cre mice was due to the expression of Cre protein, we took advantage of the inducible nature of Cre gene in OsxCre mice. The Cre expression in Osx-Cre mice is regulatable in a tet-off manner [2] . Therefore, treatment with doxycycline can prevent the expression of the GFP-Cre fusion protein and recombination of the target gene. We fed the Osx-Cre mice in mating units with doxycycline food in a continuous manner and analyzed the skeleton of the offspring of these mice. To determine whether indeed doxycycline treatment could prevent the expression of Cre recombinase, we crossed Osx-Cre mice with Rosa26 reporter mice and examined the effect of doxycycline treatment on LacZ expression. As expected, there was strong X-Gal staining in the frontal, parietal, nasal bone of Rosa26;Osx-Cre mice without doxycycline treatment. However, there was only minimal X-Gal positive staining in these areas in Rosa26;Osx-Cre mice with doxycycline treatment, indicating that doxycycline treatment effectively inhibited Cre expression (Fig. 5a ). Next, we performed skeleton staining for the control and Osx-Cre mice at birth with doxycycline treatment. We found that the hypomineralization phenotype in Osx-Cre mice was completely rescued after doxycycline treatment (Fig. 5b) , suggesting that the phenotype may be caused by the Cre expression.
Osx-Cre Did not Affect Osteoblast In Vitro Differentiation
We previously showed that deletion of gene of interest with Osx-Cre greatly compromised in vitro osteoblast differentiation [12] . This prompted us to ask whether this was due to the effect of Osx-Cre itself. We digested primary osteoblasts from the parietal bone of neonatal control and OsxCre mice. In Osx-Cre mice, the Cre is fused with GFP under the control of Osterix promoter [2] . As expected, the primary calvarial osteoblasts isolated from Osx-Cre mice had positive nucleus GFP signal while it was absent in control cells (Fig. 6a) . We cultured these calvarial osteoblasts in osteoblast differentiation medium and perform alkaline phosphatase staining at day 7 and Alizarin red staining at day 21. We observed similar staining pattern in Cre expressing osteoblast culture compared to that in control culture, suggesting that Cre expression in primary calvaria osteoblasts had no negative effect on both early and late osteoblast differentiation in vitro.
Discussion
Davey et al. reported a cortical bone phenotype in skeletally immature Osx-Cre mice [10] . Razidlo et al. reported a minor craniofacial defect in the skulls of 5.5-week-old Osx-Cre mice [7] . In this study, we reported a severe intramembranous bone formation defect in Osx-Cre mice during the early postnatal stage. Interestingly, the mineralization defect in these mice gradually recovered during development and largely disappeared by 3 weeks of age. Furthermore, doxycycline treatment can completely rescue these defects. Cre recombinase is known to have possible toxic effects that can compromise normal cell cycle and survival. High levels of Cre recombinase expression in the nucleus of neuronal progenitors can compromise normal brain development [16] . High-level myocardial expression of Cre recombinase can lead to dilated cardiomyopathy [17] . A similar mechanism may explain the hypomineralization phenotype in Osx-Cre mice. To support this notion, we found levels of Cre expression in the calvaria of Osx-Cre mice were more than twofold higher at birth than at 3 weeks of age. Increased calvarial Cre expression in newborn Osx-Cre mice is consistent with a higher Osterix expression level. Osterix mRNA levels did not differ between control and Osx-Cre mice at either age which suggests that introducing the GFP::Cre construct into exon 1 of the Osterix gene did not alter its endogenous expression. Importantly, we found that doxycycline treatment could completely rescue the defective mineralization phenotype with concomitant inhibition of Cre recombinase expression which further supports the idea that the hypomineralization phenotype in Osx-Cre mice was due to the Cre expression. Davey et al. also suggested that the Cre expression may directly contribute to the cortical bone phenotype in the skeletally immature Osx-Cre mice [10] . In Osx-Cre mice, there is a Tet-controlled transactivator, tTA, cassette placed upstream of GFP::Cre. tTA is a fusion protein of an Escherichia coli Tet repressor (TetR) and the transcriptional transactivation domain of herpes simplex virus protein 16 (VP16AD) [18] . It has been reported that overexpression of tTA can result in disruption of transcriptional machinery and thus decreases the expression of other genes [19] . tTA expression in Osterix-expressing osteoblasts may lead to similar cellular damage; however, the rescue of the phenotype by doxycycline treatment argues against this possibility. tTA expression is under the control of the endogenous Osterix promoter and is not affected by doxycycline treatment which only prevents the binding of tTA to tetracycline-responsive element (TRE). This suggests that the expression of rTA is not responsible for functional defects in osteoblasts of Osx-Cre mice.
Although it is widely accepted that Osterix is expressed specifically by osteoblasts, some recent studies identified the Osterix expression in several non-osteoblast-lineage cells including olfactory glomerular cells, a subset of the gastric and intestinal epithelium, adipocytes, and perivascular cells in the bone marrow [20] [21] [22] . This raised the possibility that the craniofacial bone development phenotype in Osx-Cre mice may be indirectly due to the nonosseous expression of GFP::Cre. Although it remains a possibility, normal body weight and general skeletal development observed in newborn Osx-Cre mice indicated defective localized intramembranous bone formation in craniofacial bones is not likely due to the systemic or indirect effect of Cre expression in other tissues.
Cre and GFP are fusion proteins under the control of the Osterix promoter, so higher levels of Cre expression detected shortly after birth could suggest increased GFP expression which may contribute to the hypomineralization phenotype. Although expression of GFP is considered to be innocuous for cells, cytotoxic effects have been demonstrated in both in vitro and in vivo studies [23, 24] . It remains to be determined the extent to which Cre or GFP contributed to the in vivo hypomineralization phenotype. Nevertheless, our current finding as well as others [10] underscored the importance of using appropriate controls for data analysis when the Cre/loxP system is used to generate tissue-specific gene knockout mice. Ideally, all CKO mice should have Cre-positive littermate controls; however, the efficiency of producing both Cre control and CKO of the same gender in one litter from breeding Flox/ ?;Cre mice and Flox/? mice is extremely low. This practical limitation precluded the ideal approach for many study designs. If we thoroughly characterize the tissuespecific effect due to Cre expression in a given tissue of interest, then we will have greater confidence when reaching conclusions from breeding experiments where Flox/Flox mice are used as controls. For example, we and others have shown that Osx-Cre itself has no effect on trabecular bone parameters [10, 12, 25] . Thus, any trabecular bone parameter changes observed in a given CKO mice with Osx-Cre are likely due to the deletion of target gene but not the expression of Osx-Cre itself. On the other hand, attributing any cortical bone parameter changes or intramembranous bone development at early stages to the gene of interest should be done cautiously. Osx-Cre-positive littermate controls would be required to draw definitive conclusion in the latter case.
Primary calvaria osteoblast culture is a well-established cell culture system to study in vitro osteoblast differentiation. The observation that Osx-Cre caused significantly compromised osteoblast mineralization function in vivo raised the question about whether it would affect in vitro osteoblast differentiation and mineralization. It is important to address this because the conclusion will affect the interpretation for all in vitro primary calvarial osteoblast differentiation experiments which utilize Osx-Cre mice to delete any gene of interest. Our data demonstrated that both the early and terminal differentiation of primary calvarial osteoblasts isolated from neonatal Osx-Cre mice was comparable to control cells. It is unclear why Osx-Cre expression had adverse effect on mineralization in early postnatal calvaria in vivo but not in isolated primary calvarial osteoblasts in vitro. It remains to be determined whether the difference between in vitro culture and in vivo bone is due to the different Cre expression level. Nevertheless, our data validated the application of this in vitro osteoblast differentiation culture system when Osx-Cre is used to delete the gene of interest.
